MTaPS’ COVID-19 Pandemic Response Support

The Challenge

COVID-19 has been a defining global health crisis in our journey to stronger health systems. When the outbreak of the novel coronavirus started in early 2020, it became an urgent call to rapidly mobilize responses in countries to mitigate its effects. But since then, responding to the pandemic has also opened opportunities on the sidelines to further strengthen health systems in countries for long-lasting gains like greater resilience and equitable, quality health care delivery—the goal of USAID.

Committed to fighting the pandemic and building back better, USAID tasked its Medicines, Technologies, and Pharmaceutical Services (MTaPS) program to be a partner in USAID’s global response to the pandemic.

MTaPS’ Technical Areas of Support

To support USAID’s global pandemic response, MTaPS provided rapid technical assistance to 13 countries. MTaPS applied evidence-based approaches and drew upon the multisectoral coordination networks and partnerships developed through its infection prevention and control (IPC) work under the Global Health Security Agenda (GHSA) to rapidly build capacities of the health workforce for mitigating and managing infections. Upon approval of COVID-19 vaccines for immunization, MTaPS applied its pharmaceutical systems expertise across the spectrum—from regulatory and policy support to introduce new health technologies (such as vaccines and diagnostics) to procurement and supply chain logistics management, vaccine safety monitoring, and human resources capacity development to facilitate COVID-19 vaccine deployment.

MTaPS is aligned with the U.S. COVID-19 Global Response and Recovery Framework and supports two objectives:

Objective 1: Accelerate equitable
access to and delivery of safe
and effective COVID-19
vaccinations

  • Policy, regulation, coordination, and implementation planning
  • Guides and tools for vaccine introduction
  • Vaccine-related human resources capacity building
  • Vaccine safety monitoring and reporting
  • Safe vaccine services delivery, IPC, and waste management 
  • Vaccine procurement, supply chain, and logistics
  • Risk communications and advocacy

Objective 2: Reduce morbidity and mortality from COVID-19, mitigate transmission, and strengthen health systems, including future pandemic response

  • Coordination and operations for COVID-19 response and mitigation 
  • COVID-19 infection prevention and control capacity building from national to health facility level
  • Monitoring COVID-19 IPC standards compliance at facilities
  • Integrating continued IPC improvements in health systems 
  • Managing COVID-19 IPC commodities at the national and facility level

Impact in Numbers

Developed COVID-19 Infection Prevention and Control (IPC) Capacities in 13 Countries (data as of March 2022)
Supporting Introduction and Deployment of COVID-19 Vaccines in 11 Countries (data as of March 2022)